What it is

DayZero Umbilical Cord-Derived Stem Cells is an allogeneic cellular preparation derived from umbilical cord tissue, manufactured by ZEO ScientifiX, Inc., a Florida-based regenerative biologics company and SEC-registered public filer. The product is supplied in an intravenous format.

Source & manufacturing

Umbilical cord tissue is a birth tissue (perinatal) source. This material is allogeneic, meaning it is donor-derived rather than sourced from the patient receiving it. ZEO ScientifiX holds patents on perinatal-fluid and birth-tissue processing techniques and maintains an active clinical research portfolio. Cells are sourced from AABB-accredited, FDA-registered facilities. TC Regen sources this material from ZEO ScientifiX as a documented supplier.

How TC Regen uses it

At TC Regen Naples and TC Regen Fort Myers, DayZero Umbilical Cord-Derived Stem Cells is administered exclusively under the direct supervision of a licensed physician. Whether this material is included in a patient's plan is a diagnosis-driven decision. A physician evaluates each patient's condition individually before any determination is made, and no protocol is applied uniformly across patients.

Regulatory status

This product is not FDA-approved. Umbilical cord-derived stem cell preparations are allogeneic birth-tissue biologics subject to the highest level of FDA scrutiny, and intravenous administration carries the most stringent regulatory profile among delivery methods. TC Regen administers this material in compliance with Florida's Stem Cell Therapy Act, which mandates written informed consent and explicit disclosure that the therapy is not FDA-approved prior to any administration. No therapeutic outcomes are promised or implied.